Answers are grounded in this paper and cite their sources.
A chronic schizophrenic patient developed a fatal agranulocytosis 1 month after beginning to take carbamazepine for aggression. Routine hematological monitoring was not carried out. This case highlights the need for psychiatrists' increased awareness of the possible hematological complications of carbamazepine.
No takes yet. Share an insight, caveat, or question.
D J Luchins (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: